Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03435952
Recruitment Status : Recruiting
First Posted : February 19, 2018
Last Update Posted : August 30, 2021
Sponsor:
Collaborators:
BioMed Valley Discoveries, Inc
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : October 2021